399 related articles for article (PubMed ID: 1678278)
1. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy.
Caughey BW; Dong A; Bhat KS; Ernst D; Hayes SF; Caughey WS
Biochemistry; 1991 Aug; 30(31):7672-80. PubMed ID: 1678278
[TBL] [Abstract][Full Text] [Related]
2. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
[TBL] [Abstract][Full Text] [Related]
3. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
J Biol Chem; 1993 Sep; 268(27):20276-84. PubMed ID: 8104185
[TBL] [Abstract][Full Text] [Related]
4. Separation of scrapie prion infectivity from PrP amyloid polymers.
Wille H; Zhang GF; Baldwin MA; Cohen FE; Prusiner SB
J Mol Biol; 1996 Jun; 259(4):608-21. PubMed ID: 8683568
[TBL] [Abstract][Full Text] [Related]
5. Conservation of infectivity in purified fibrillary extracts of scrapie-infected hamster brain after sequential enzymatic digestion or polyacrylamide gel electrophoresis.
Brown P; Liberski PP; Wolff A; Gajdusek DC
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7240-4. PubMed ID: 2119503
[TBL] [Abstract][Full Text] [Related]
6. Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins.
Rubenstein R; Merz PA; Kascsak RJ; Scalici CL; Papini MC; Carp RI; Kimberlin RH
J Infect Dis; 1991 Jul; 164(1):29-35. PubMed ID: 1676044
[TBL] [Abstract][Full Text] [Related]
7. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity.
Gasset M; Baldwin MA; Fletterick RJ; Prusiner SB
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):1-5. PubMed ID: 8419912
[TBL] [Abstract][Full Text] [Related]
8. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
[TBL] [Abstract][Full Text] [Related]
9. Isolation and purification of scrapie-associated fibrils and prion protein from scrapie-infected hamster brain.
Liberski PP; Plucienniczak A; Hrabec E; Bogucki A
J Comp Pathol; 1989 Feb; 100(2):177-85. PubMed ID: 2565919
[TBL] [Abstract][Full Text] [Related]
10. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
11. Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells.
Caughey B; Neary K; Buller R; Ernst D; Perry LL; Chesebro B; Race RE
J Virol; 1990 Mar; 64(3):1093-101. PubMed ID: 1968104
[TBL] [Abstract][Full Text] [Related]
12. Strain-dependent differences in beta-sheet conformations of abnormal prion protein.
Caughey B; Raymond GJ; Bessen RA
J Biol Chem; 1998 Nov; 273(48):32230-5. PubMed ID: 9822701
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.
Baron GS; Hughson AG; Raymond GJ; Offerdahl DK; Barton KA; Raymond LD; Dorward DW; Caughey B
Biochemistry; 2011 May; 50(21):4479-90. PubMed ID: 21539311
[TBL] [Abstract][Full Text] [Related]
14. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology and transgenetics of prion diseases.
Prusiner SB
Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
[TBL] [Abstract][Full Text] [Related]
16. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
17. Molecular characteristics of the major scrapie prion protein.
Bolton DC; McKinley MP; Prusiner SB
Biochemistry; 1984 Dec; 23(25):5898-906. PubMed ID: 6395885
[TBL] [Abstract][Full Text] [Related]
18. N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.
Caughey B; Raymond GJ; Ernst D; Race RE
J Virol; 1991 Dec; 65(12):6597-603. PubMed ID: 1682507
[TBL] [Abstract][Full Text] [Related]
19. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
Vorberg I; Chan K; Priola SA
J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation.
Xi YG; Ingrosso L; Ladogana A; Masullo C; Pocchiari M
Nature; 1992 Apr; 356(6370):598-601. PubMed ID: 1348570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
